Companies / Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

Nasdaq: PLRXCIK 1746473SOUTH SAN FRANCISCO, CApliantrx.com ↗

Financials · FY2025

Revenue$0
Net income$-149.34M
Total debt$0
Cash$24.88M
Diluted EPS$-2.43
Shares outstanding61.9M

Ownership

61.9M shares outstanding · as of Aug 7, 2026
1.4%Insiders
Ownership
Insiders1.43%885,468
Institutions80.89%50,089,989
Public float17.68%10,946,440

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Coulie BernardCEOPresident and CEO · Director
0.82%505,601
Cummings Keith LamontChief Financial Officer
0.48%297,214
Cheung LilyChief Human Resource Officer
0.07%44,847
Kuo MinnieChief Operating Officer
0.06%37,806
Crowell Gayle aDirector
——

Institutional holders 101

View all →
HolderValue% of shares
Tang Capital Management, LLC$7.74M9.92%
Blue Owl Capital Holdings LP$3.62M4.80%
Vanguard Group Inc$3.44M4.55%
Citadel Advisors LLC$3.15M4.17%
Two Sigma Investments, LP$2.84M3.64%
Woodline Partners LP$2.47M3.27%
Renaissance Technologies LLC$2.33M2.99%
Monaco Asset Management SAM$2.21M3.13%
Redmile Group, LLC$1.97M2.61%
Prosight Management, LP$1.90M2.51%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 20, 2026Coulie Bernard
CEO
SellCommon Stock$114.4K-89K
-15.02%
505,601
0.82% of shares
medium
Jan 20, 2026Cummings Keith Lamont
Executive
SellCommon Stock$30.7K-24K
-7.47%
297,214
0.48% of shares
low
Jan 20, 2026Cheung Lily
Executive
SellCommon Stock$9.6K-8K
-14.38%
44,847
0.07% of shares
low
Jan 20, 2026Kuo Minnie
Executive
SellCommon Stock$8.9K-7K
-15.47%
37,806
0.06% of shares
low
Jun 11, 2026Crowell Gayle a
Director
GrantStock Option (Right to Buy)—+70K
70,000
0.11% of shares
low
Jan 22, 2026Cummings Keith Lamont
Executive
GrantStock Option (Right to Buy)—+400K
400,000
0.65% of shares
low
Jan 22, 2026Coulie Bernard
CEO
GrantStock Option (Right to Buy)—+1.2M
1,230,000
1.99% of shares
low
Jan 22, 2026Kuo Minnie
Executive
GrantStock Option (Right to Buy)—+300K
300,000
0.48% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Citadel Advisors LLCPassive13G———
Citadel Advisors LLCPassive13G———
Citadel Advisors LLCPassive13G———
Point72 Asset Management, L.P.Passive13G/A———
Morgan StanleyPassive13G/A———
Woodline Partners LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PLRXCommon StockEquity729139105BBG00C8083N4